Related Experiment Video
Updated: Jun 30, 2025

05:37
Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
610
Targeting proto-oncogene B-MYB G-quadruplex with a nucleic acid-based fluorescent probe
Pedro Lourenço1, André Miranda1, Maria Paula Cabral Campello2
1CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
International Journal of Biological Macromolecules
|March 24, 2024
Summary
Researchers developed a novel probe to target G-quadruplexes (G4s) in the B-MYB oncogene promoter, crucial for lung cancer. This probe stabilizes G4s, offering potential for new cancer therapies.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- The B-MYB gene is vital for cell growth and survival, with abnormal expression linked to lung cancer.
- Oncogenes, including B-MYB, can form G-quadruplex (G4) structures in their promoter regions, influencing gene regulation.
- These G4 structures represent potential targets for cancer drug development.
Purpose of the Study:
- To design and characterize a probe for specifically identifying a G-quadruplex in the B-MYB gene promoter.
- To investigate the interaction of acridine derivative ligands with the B-MYB G4 structure.
- To assess the potential of this probe and ligands for therapeutic applications in lung cancer.
Main Methods:
- Design of a probe combining an acridine derivative ligand with a DNA segment complementary to the target G4 sequence.
- Biophysical characterization including stability, affinity, and fluorescence studies of the probe-G4 interaction.
- Cellular studies to confirm G4 formation, probe co-localization, and the effect of ligands on G4s in vivo.
Main Results:
- Acridine derivative ligands (C5NH2, C8NH2) effectively stabilized the B-MYB G4 structure with moderate affinity.
- Ligands altered G4 topology and showed enhanced fluorescence upon binding, indicating successful G4 interaction.
- The target sequence formed a G4 structure, even with a nucleotide tail, and cellular studies confirmed probe co-localization.
Conclusions:
- A specific probe and acridine ligands were developed to target the B-MYB gene promoter G4.
- These findings demonstrate the potential of targeting B-MYB G4s for lung cancer therapy.
- The study validates the formation and detection of G4 structures in the B-MYB oncogene promoter.

